The present study was undertaken to investigate the effect of in vivo administration of neem oil intra-peritoneally (i.p.) to mice bearing a progressively growing transplantable T cell lymphoma of spontaneous origin, designated as Daltons lymphoma (DL), on the tumor growth. Mice were administered various doses of neem oil mixed in groundnut oil, which was used as a diluting vehicle or for administration to control DL-bearing mice. Administration of neem oil resulted in an acceleration of tumor growth along with a reduction in the survival time of the tumor-bearing host. Neem oil administered DL-bearing mice showed an augmented apoptosis in splenocytes, bone marrow cells and thymocytes along with an inhibition in the anti-tumor functions of tumorassociated macrophages. Thus this study gives an altogether a novel information that neem oil instead of the popular belief of being anti-tumor and immunoaugmentary may in some tumorbearing conditions, behave in an opposite way leading to an accelarated tumor progression along with a collapse of the host's anti-tumor machinery. These observations will thus have long lasting clinical significance, suggesting caution in use of neem oil for treatment of cancer.
INTRODUCTION
Herbal drugs with immunomodulatory properties are being evaluated for their possible anticancer activity. These drugs act by reversing the immunosuppression induced by cancer growth (Singh et al., 2005a (Singh et al., ,b, 2006 . However, different type of tumors shows different responses to anticancer drugs. Therefore, an understanding for mechanism of immunosuppression, with respect to each individual tumor clone and the effect of various immunomodulatory drugs is essential for a successful implementation of immunotherapeutic protocol. Considering the importance to study the effect of such drugs on tumors of spontaneous origin, we have been investigating the effect of progressive in vivo growth of a murine transplantable T-cell lymphoma designated as Daltons Lymphoma (DL) (Klein, 1951) on the immune status of tumor bearing host. DL growth has been shown to result in a massive suppression of cellular and humoral immune responses and hematopoiesis in the tumor-bearing mice (Bharti and Singh, 2000 , 2001 , 2003 . Further it was demonstrated that extract prepared from herb called Tinospora cordifolia could modulate DL growth through its direct antitumor activity and through its up-regulating effect on the antitumor activity of tumor associated macrophages and hematopoiesis in the tumor-bearing host (Singh et al., , 2005a (Singh et al., ,b, 2006 . However, it remains unclear if DL growth and associated antitumor immunity also responds to other herbal preparations.
Neem (Azadirachta indica) has been shown to posses many curative properties in traditional medicine and its several medical applications are well recognized. The activity of neem with the crude extracts, their different fractions and active components have been studied (Koul et al., 2004) . Neem oil has been shown to possess immunomodulatory properites (Upadhyay et al., 1992) and polysaccharides isolated from neem bark have shown to inhibit the growth of sarcoma 180 (Fujiwara et al., 1982) . However, it remains unclear if products derived from neem oil can also alter the growth of a T-cell lymphoma and related antitumor immunity.
In view of the above observations the present investigation was carried out to study the effect of neem oil on the progression of DL and the related immunological consequences in the mice
MATERIALS AND METHODS
Mice, tumor system and cell lines Pathogen-free inbred adult male and female mice of BALB/c (H-2 d ) strain were used at 8 -12 w of age. The mice received food and water ad libitum and were treated with utmost human care in an approved and certified animal room facility of the Banaras Hindu University at the Institute of Medical Sciences. For all purposes mice were killed by cervical dislocation. DL is maintained in ascitic form by serial transplantation in BALB/c mice or in an in vitro cell culture system by serial passage as described earlier (Bharti and Singh, 2003) . Irrespective of whether the DL cells were obtained from the in vitro culture system maintained as suspension cultures or from the ascitic fluid they exhibited similar phenotypic features. A stock of DL cells is also maintained in a cryopreserved state for reference purpose. In all the experiments, the cells obtained from the ascitic fluid, where the yield of DL cells is highest, were used. Serial passaging of DL in mice was carried out by transplanting 1 × 10 5 DL cells mouse -1 , in 0.5 ml phosphate buffered saline (PBS). Mice thus transplanted with DL cells survive for an average of 20 ± 2 days. L929, a TNF-sensitive murine fibroblast cell line, was obtained from National Center for Cell Science (Pune, India) and was maintained in the laboratory, for bioassay of tumor necrosis factor (TNF), by serial passaging in culture. 0.25% (w/v) solution of trypsin in PBS containing 1 mM EDTA was used for trypsinization of adherent L929 cells. All the cell cultures were maintained in a CO 2 incubator with humidified atmosphere containing a mixture of 95% air and 5% CO 2 .
Reagents
All tissue culture plastics-wares were purchased from Tarsons (India). Tissue culture medium RPMI 1,640 was purchased from Hyclone (Logan, Utah). Commercially available preparation of neem oil was purchased from Baidyanath, Allahabad, India. All other reagents and antibiotics were purchased from Himedia (Bombay) unless mentioned otherwise. Culture media was supplemented with 20 µg/ml gentamycin, 100 µg/ml streptomycin, 100 IU penicillin purchased from and 10% fetal calf serum from Hyclone (Logan, Utah), henceforth, referred as complete medium, medium without serum was designated as incomplete medium. All the reagents used in the experiments were determined to be endotoxin-free by Limulus Amoebocyte lysate assay (sensitivity limit: 0.1 ng ml
).
Isolation of tumor-associated macrophages (TAM)
Mice, with or without DL, were killed by cervical dislocation and peritoneal exudate cells (PEC) were harvested by peritoneal lavage as described earlier (Singh et al., 2005c) . The PEC were cultured in plastic tissue culture flasks (Greiner, Germany) at 37 o C in a CO 2 incubator for 2 h. The cultures were then washed thrice with warm serum-free medium with gentle flushing to ensure that all the DL and/or other non-adherent cells were removed. Approximately 95% of the adherent cell population was macrophages as determined by morphology. The TAM were detached from the tissue Culture flask with a cell scraper and plated in a 96 well flat bottom culture plate (1.5 × 10 5 cells/well).
Study of tumor progression and survival of tumor bearing mice Tumor growth was monitored by measuring increase of the body weight and enumeration of tumor cells in the ascitic fliud of control and experimental groups of DL-bearing mice, upto day 21 following a method described earlier (Singh et al., 2005c,d) . The percent increase in body weight was calculated as follows:
Where, W f = Weight of mice on day 21 of tumor transplantation; W i = Weight of mice on day 1 of tumor transplantation. DL-bearing control or experimental mice were allowed to live under normal conditions until death. The day of death in each case was noted and the results were shown as percent survival on a standard Kaplan Meier plot (Singh et al., 2005c,d) .
Estimation of tumor cell survival in vitro by MTT assay Tumor cell survival was assayed according to a method described earlier (Singh et al., 2005a) . DL cells were seeded (1.5 × 10 5 viable cells well
), in a 96 well tissue culture plate in culture conditions mentioned in the results section for 72 h. Cell survival was measured by MTT assay following a method described by Mosmann (1983) with slight modifications. MTT was dissolved in PBS at a concentration of 5.0 mg/ml. Fifty µl of MTT solution was added to each well of the culture plate containing 200 µl medium and incubated at 37ºC for 4 h. The plate was then centrifuged at 100 × g for 5 min at 4 o C (Remi, New Delhi, India). The supernatant was then carefully removed without disturbing the dark blue formazan crystals. One hundred µl of the DMSO was added to each well and mixed thoroughly to dissolve the formazan crystals. The plates were then read on a microplate reader (Labsystems, Helsinki, Finland) at a wavelength of 540 nm. Readings are presented as absorbance at 540 nm.
Assay of TNF activity
The activity of TNF in the culture supernatant of TAM was measured by dye uptake assay as described earlier (Singh et al., 2006a) . Briefly, 3 × 10 4 L929 cells, in 100 µl medium were grown in wells of a 96 well tissue culture plate in the presence of 1 µg/ml of Actinomycin-D and 100 µl of the test culture supernatant. After 18 h of incubation the plates were washed and cell lysis was determined by staining the plate with a 0.5% (w/v) solution of crystal violet in methanol/water (1: 4 v/v). The OD was measured at 540 nm.% Cytotoxicity was calculated as follows:
Where C is the absorbance of wells containing L929 cells incubated in medium alone, and T is that of those wells in which L929 cells were incubated with culture supernatant of TAM.
Percent DNA fragmentation Induction of apoptotic mode of cells death in cells was also confirmed by quantitative determination of DNA fragmentation following a method given by Sellins and Cohen (1987) with slight modifications (Singh et al., 2006b) . Cells (1.5 × 10 6 cells ml -1
) were lysed in 0.5 ml of Tris-EDTA buffer, pH 7.4, containing 0.2% (v/v) Triton X-100 and the fragmented DNA was separated from intact chromatin in a microfuge tube (labeled as B) by centrifugation at Sanjaya Kumar Mallick et al.
13,000 × g at 4ºC for 10 min. Supernatant containing the fragmented DNA was transferred to another microfuge tube (labeled as T). A volume of 0.5 ml of 25% TCA was added to each T and B tube and vortexed vigorously. DNA was precipitated overnight at 4ºC and collected at 13,000 × g at 4ºC for 10 min. Supernatant was discarded and 80 µl of 5% TCA was added to each pellet. DNA was hydrolyzed by heating at 90ºC for 15 min. At this stage a blank was included containing 80 µl of 5% TCA. Then 160 µl of freshly prepared diphenylamine (DPA) reagent (150 mg diphenyleamine in 10 ml glacial acetic acid, 150 µl concentrated H 2 SO 4 and 50 µl of acetaldehyde solution) was added and the tubes were allowed to stand overnight at room temperature to develop color. One hundered µl of this colored solution was transferred to the wells of a 96-well flat-bottomed ELISA plate and absorbance was measured at 600 nm in a microtitre ELISA plate reader (Labsystems, Finland). Percent DNA fragmentation was calculated as:
DNA fragmentation (%) = [T / (T+B)] ×100
Where T = absorbance of fragmented DNA and T + B = absorbance of total DNA.
Statistical analysis
The statistical significance of the difference between the test groups was analyzed by the Student's t-test (two tailed). The difference was considered significant when the P value was less than 0.05. All the experiments were done in triplicate and repeated at least three times.
RESULTS

Effect of neem oil on progression of DL in vivo
In the first part of experiment the effect of in vivo administration of neem oil on DL progression was investigated. Neem oil was administered i.p. to DL-bearing mice after 2 days of DL transplantation at doses of 100, 300 and 500 mg/kg body weight and progression of tumor growth was monitored by taking the body weight of DL-bearing mice on a daily basis. The percent increase in body weight of DL-bearing mice was found to significantly increase upon administration of neem oil in a dose dependent manner (Fig. 1 ) as compared to DL-bearing mice administered with vehicle, groundnut oil.
Effect of neem oil on the survival of DL-bearing mice
The effect of i.p. administration of neem oil on the survival of DL-bearing mice was also investigated. The survival of DL-bearing mice upon administration of neem oil (300 mg/kg) was found to decrease as compared to the group treated with vehicle alone (Fig. 2) . Administration of neem oil at same doses for a similar period of time to normal mice did not decrease the survival of these mice (data not shown). Effect of neem oil on the DNA fragmentation of BMC, splenocytes and thymocytes We also studied the percent DNA fragmentation of BMC, thymocytes and splenocytes obtained from DL-bearing or normal mice treated with neem oil or vehicle. Results are shown in Table 1 . BMC, thymocytes and splenocytes from neem oil-treated mice showed a significantly higher DNA fragmentation as compared to vehicle treated group.
Effect of neem oil on TNF production by tumor associated macrophages TNF produced by TAM obtained from DL-bearing mice treated with different doses of neem oil was studied in Fig. 3 . TNF production was found to remain comparable between the vehicle or neem oil administrated mice. However, TNF production was found to significantly get inhibited at a dose of 500 mg/kg body weight of neem oil. ) obtained from DL-bearing mice with or without neem oil administration and cell survival was estimated by MTT assay as described in the materials and methods. Results are shown in Fig. 4 . It was found that neem oil administration resulted in a signifant augmentation in the survival of DL cells compared to DL cells obtained from mice administered with vehicle alone. 
DISCUSSION
In the present investigation we have studied the effect of neem oil on the progression of a transplantable T cell lymphoma designated as DL. Neem oil has been shown to have a modulatory effect on the immune system (Upadhyay et al., 1992) and similar nature of immunostimulation was also seen with neem leaf extract (Ray et al., 1996) and neem derived polysaccharides (Fujiwara et al., 1982) . Inspite of these findings the effect of neem oil on tumor growth remains neglected. Our investigation is novel and first of its kind. Till date no one has reported the effect of neem oil on progression of any T cell tumor. Contradictory to the findings of Fujiwara (1982) , our observation suggests an increased growth of DL in mice treated with neem oil. Intraperitoneal administration of neem oil was shown to accelerate DL growth and resulted in early death of DL-bearing mice compared to tumor-bearing mice not treated with neem oil. The inhibition of TNF production by macrophage upon neem oil administration suggests that TAM with a decreased anti-tumor activity may have provided a conducive growth environment for DL cells. Moreover we have earlier reported that TAM contributes directly to the promotion of DL growth (Parajuli and Singh, 1996) . The difference of these observations from that of Upadhyay et al. (1992) could be due to the fact that they used normal macrophages which are responsive for activation whereas in the present study we used TAM which we have demonstrated to be in a suppressed state and are unresponsive to activation signals (Parajuli et al., 1997) . On the basis of the observations of the present study we suggest that crude neem oil contains some components, which help in progression of DL.
However, it is not clear if neem oil will have similar effects on others tumors as well. An additional cause for accelerated DL growth could be action of neem oil on components of immune system. Indeed we observed that higher doses of neem oil administration resulted in the induction of apoptosis of lymphocytes. Since neem oil has been shown to stimulate T cell proliferation at optimum dose (Upadhyay et al., 1992) and that DL is itself a T cell tumor, a direct mutagenic effect of neem oil on DL cells may also be a reason for the augmented DL growth on neem oil administration. The possibility that neem oil may have a different action on tumor growth if administered orally or through other route needs to be investigated. In the present study neem oil was administered directly into the peritoneal cavity where DL cells were growing. So the action of neem oil could be a direct one on tumor cells rather than that of its metabolized products.
Despite unsolved problem the results of the present study are of unique significance as they shows that neem oil when administered i.p. to T cell lymphoma bearing host may support tumor growth rather than inhibiting it, as reported with other tumors and will have long lasting clinical applications in designing anticancer therapies with neem oil. 
